These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24337404)

  • 21. Liver-specific deletion of LASS2 delayed regeneration of mouse liver after partial hepatectomy.
    Jin H; Wang C; Gu D; Zhang Y; Fan S; Xing S; Wang H; Ruan H; Yang C; Lv Y; Feng H; Yao M; Qin W
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1176-1183. PubMed ID: 28958935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnane X receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F
    Shi T; Fan QY; Liu SB; Zhang SY
    Biochem Pharmacol; 2024 Jul; 225():116309. PubMed ID: 38788959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
    Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
    Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
    Bopp A; Wartlick F; Henninger C; Schwarz M; Kaina B; Fritz G
    Carcinogenesis; 2015 Mar; 36(3):378-89. PubMed ID: 25556150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
    Yang X; Tang J; Rogler CE; Stanley P
    Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
    Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
    PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
    Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
    Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
    Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
    Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine.
    Santos NP; Pereira IC; Pires MJ; Lopes C; Andrade R; Oliveira MM; Colaço A; Peixoto F; Oliveira PA
    In Vivo; 2012; 26(6):921-9. PubMed ID: 23160673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.
    Tsujino T; Naito Y; Kawasaki D; Okuda S; Sakoda T; Fujioka Y; Sugaya T; Ohyanagi M
    Clin Exp Hypertens; 2005; 27(2-3):159-68. PubMed ID: 15835378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
    Xu X; Liu B; Zou P; Zhang Y; You J; Pei F
    J Cell Biochem; 2014 Apr; 115(4):731-43. PubMed ID: 24453046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice.
    Sun C; Kono H; Furuya S; Hara M; Hirayama K; Akazawa Y; Nakata Y; Fujii H
    Dig Dis Sci; 2016 Feb; 61(2):474-88. PubMed ID: 26467699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Krüppel-like factor 10 null mice exhibit lower tumor incidence and suppressed cellular proliferation activity following chemically induced liver tumorigenesis.
    Heo SH; Jeong ES; Lee KS; Seo JH; Lee WK; Choi YK
    Oncol Rep; 2015 Apr; 33(4):2037-44. PubMed ID: 25682863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.